Learn More
Medchemexpress LLC Riviciclib hydrochloride | 920113-03-7 | 99.08% | 438.30 | 25 MG

Supplier: Medchemexpress LLC 25MGHY16559
Riviciclib hydrochloride is a potent cyclin-dependent kinase (CDK) inhibitor. It inhibits CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively. This compound shows antitumor activity on cisplatin-resistant cells.
- IC50 & Target information available
- In vitro studies show activity in various cancer cell lines
- In vivo studies demonstrate significant inhibition of tumor growth
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.